WallStSmart

Boston Scientific Corp (BSX)vsPure Storage Inc (PSTG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Boston Scientific Corp generates 448% more annual revenue ($20.07B vs $3.66B). BSX leads profitability with a 14.4% profit margin vs 5.1%. BSX appears more attractively valued with a PEG of 0.75. BSX earns a higher WallStSmart Score of 63/100 (C+).

BSX

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 6.5Value: 8.7Quality: 5.5
Piotroski: 4/9

PSTG

Buy

59

out of 100

Grade: C

Growth: 8.0Profit: 5.0Value: 4.7Quality: 5.3
Piotroski: 4/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BSXUndervalued (+1.1%)

Margin of Safety

+1.1%

Fair Value

$70.25

Current Price

$69.48

$0.77 discount

UndervaluedFair: $70.25Overvalued
PSTGSignificantly Overvalued (-195.4%)

Margin of Safety

-195.4%

Fair Value

$25.74

Current Price

$62.63

$36.89 premium

UndervaluedFair: $25.74Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BSX4 strengths · Avg: 8.3/10
Market CapQuality
$103.10B9/10

Large-cap with strong market position

PEG RatioValuation
0.758/10

Growing faster than its price suggests

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

Free Cash FlowQuality
$1.01B8/10

Generating 1.0B in free cash flow

PSTG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
140.6%10/10

Earnings expanding 140.6% YoY

Revenue GrowthGrowth
20.4%8/10

Revenue surging 20.4% year-over-year

Areas to Watch

BSX1 concerns · Avg: 4.0/10
P/E RatioValuation
36.0x4/10

Premium valuation, high expectations priced in

PSTG4 concerns · Avg: 2.8/10
Price/BookValuation
14.3x4/10

Trading at 14.3x book value

Profit MarginProfitability
5.1%3/10

5.1% margin — thin

P/E RatioValuation
113.9x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BSX

The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.

Bull Case : PSTG

The strongest argument for PSTG centers on EPS Growth, Revenue Growth. Revenue growth of 20.4% demonstrates continued momentum. PEG of 1.47 suggests the stock is reasonably priced for its growth.

Bear Case : BSX

The primary concerns for BSX are P/E Ratio.

Bear Case : PSTG

The primary concerns for PSTG are Price/Book, Profit Margin, P/E Ratio. A P/E of 113.9x leaves little room for execution misses.

Key Dynamics to Monitor

PSTG carries more volatility with a beta of 1.33 — expect wider price swings.

PSTG is growing revenue faster at 20.4% — sustainability is the question.

BSX generates stronger free cash flow (1.0B), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BSX scores higher overall (63/100 vs 59/100) and 15.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Boston Scientific Corp

HEALTHCARE · MEDICAL DEVICES · USA

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Pure Storage Inc

TECHNOLOGY · COMPUTER HARDWARE · USA

Pure Storage, Inc. provides data storage technology and solutions in the United States and internationally. The company is headquartered in Mountain View, California.

Want to dig deeper into these stocks?